BioPhenoMA enters into MOU with Taiwan Exosome Inc. and Waseda University for international collaboration on the analysis of NK cell-derived exosomes.(Nikkei Biotechnology & Business)

Private investment and increased government support! The Industrial Development Agency's "Venture Capital Acceleration Innovation and Entrepreneurship Program" has upgraded its second round of applications for the first batch of 10 approved projects, whic

The Taiwan Industry Development Agency (TIDA) has approved 10 projects in the first batch of its Venture Capital Acceleration Innovation and Entrepreneurship Program.

The second round of applications for the Venture Capital Acceleration Innovation and Entrepreneurship Program is estimated to yield investment benefits exceeding 10 billion yuan.

Accelerate Investment! The Ministry of Economic Affairs has approved ten CVC (Central Venture Capital) projects, including those from Lee Chang Yung Chemical, UMC, Taiwan Cooperative Bank, and Pegatron.

Private investment and increased government support! The Industrial Development Agency's "Venture Capital Acceleration Innovation and Entrepreneurship Program" has upgraded its second round of applications for the first batch of 10 approved projects, whic

[Video] Taiwan Exosome Company Expands Large Animal Preclinical Research Through Strategic Partnership with Waseda University and BioPhenoMA (CNEWS)

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(ＦＴＶ news)

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(ＹＡＨＯＯ　ＮＥＷＳ）

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(YAM news)

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(pchome news)

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(life news)

[Usage] Deepening large animal preclinical research distribution, Taiwan exocrine system, Tianda University and BioPhenoMA promotion international collaboration(owl news)

[Video] Taiwan Exosomes Collaborates with Waseda University and BioPhenoMA to Deepen Preclinical Research in Large Animals, Promoting International Cooperation(（Polls News）

Promoting international cooperation, Taiwan's exosomes are deepening their preclinical research in large animals.(House Fun News)

Promoting international cooperation, Taiwan's exosomes are deepening their preclinical research in large animals.(TYE NEWS)

Promoting international cooperation, Taiwan's exosomes are deepening their preclinical research in large animals. (Big Media)

Promoting international cooperation, Taiwan's exosomes are deepening their preclinical research in large animals.(TAIWAN HOT)

TEC hosts forum to discuss preclinical research in large animals(（China Times News）

Promoting international cooperation, Taiwan's exosomes are deepening their preclinical research in large animals.(LINE TODAY)

TEC Announces New Exosome Initiative, Partnering with Waseda University to Advance the Next Era of Regenerative Medicine | CNEWS (youtube)

Taiwan Exosome Company (TEC) Partners with ATRI to Obtain "SPF Pig Platelet Exosome" Licensing, Targeting Billion-Dollar Global Regenerative Medicine Opportunities

Southern Taiwan University of Science and Technology Presents Industry–Academia R&D Achievements in Exosome Technology; Techniques Transferred to Japanese Team for Experimental Validation

Taiwan Exosome Company Opens a New Chapter in Regenerative Medicine! Storming the Japanese Bridgehead to Lead the Global Pharmaceutical Market

Taiwan Exosome Industry Joins Forces with National Yang Ming Chiao Tung University! Focusing on Urological Diseases

Exosome technology targets neurological health — Taiwanese startup builds an integrated academia-industry-clinical platform.

Miniature Couriers Between Cells! Taiwan Biotech Startup Targets Urological Applications to Pioneer Regenerative Medicine

Taiwan Exosome Company has established the first domestic clinical-grade universal (non-matching and non-genetically modified) NK cell platform, possessing the key capability to enter clinical trials.

Exosome Technology on the Rise — Taiwan Exosome’s Strategic Blueprint for Global Market Expansion

To enhance the overall operational efficiency of the company, the Board of Directors of Medigen Biotech Corp has resolved to form a strategic alliance with Taiwan Exosome Company.

Natural is the best！National-level Biotechnology Center dedicated to research and development「Taiwanese endemic plant-Chenopodium formosanum」

New Breakthrough in Regenerative Medicine！Dr. Du Yuan-Kun's Research:Exosomes Outperform Stem Cells

Research in regenerative medicine is a highly discussed topic in today's medical field. The research team led by Dr. Du Yuan-Kun, a domestic authority in neurological treatment from E-Da Hospital, has found that "exosomes" can effectively repair nerve injuries. This represents an important breakthrough in neuroregenerative medicine, and the results have been published in an international journal.